Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000470955 | SCV000545982 | likely benign | Baller-Gerold syndrome | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000766001 | SCV000897433 | uncertain significance | Baller-Gerold syndrome; Rapadilino syndrome; Rothmund-Thomson syndrome | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001847740 | SCV002104340 | uncertain significance | not provided | 2023-08-10 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Identified in healthy individuals undergoing whole genome sequencing (Bodian et al., 2014); This variant is associated with the following publications: (PMID: 24728327) |
Sema4, |
RCV002255300 | SCV002528313 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-11-17 | criteria provided, single submitter | curation | |
St. |
RCV004786383 | SCV005402293 | uncertain significance | Rothmund-Thomson syndrome type 2 | 2024-05-01 | criteria provided, single submitter | clinical testing | The RECQL4 c.3172C>G (p.Arg1058Gly) missense change has a maximum subpopulation frequency of 0.19% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). In silico tools predict a deleterious effect on protein function, but to our knowledge this prediction has not been confirmed by functional studies. To our knowledge, this variant has not been reported in individuals with RECQL4-associated conditions. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. |
ITMI | RCV000121945 | SCV000086152 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |